Protagenic Therapeutics Successfully Concludes Third Cohort In Single Dose Portion Of Phase 1 Trial For Stress-Related Neuropsychiatric Disorders
Protagenic Therapeutics成功完成了针对压力相关神经精神疾病的1期试验的单剂量部分的第三组队列
Protagenic Therapeutics Successfully Concludes Third Cohort In Single Dose Portion Of Phase 1 Trial For Stress-Related Neuropsychiatric Disorders
Protagenic Therapeutics成功完成了针对压力相关神经精神疾病的1期试验的单剂量部分的第三组队列
使用浏览器的分享功能,分享给你的好友吧